Factors Associated with Multidrug-resistant Tuberculosis: Comparison of Patients Born Inside and Outside of the Czech Republic

Author： Bartu V   Kopecka E   Havelkova M  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.38, Iss.3, 2010-06, pp. : 1156-1163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients

By Alffenaar Jan-Willem C.  

Clinical Pharmacokinetics, Vol. 49, Iss. 8, 2010-08 ,pp. : 559-565

Adis International

Access to resources Recommend Favorite

Treatment and Prevention of Multidrug-Resistant Tuberculosis

By Bastian I.   Colebunders R.  

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 633-661

Adis International

Access to resources Recommend Favorite

A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis

By Fitzpatrick Christopher   Floyd Katherine  

PharmacoEconomics, Vol. 30, Iss. 1, 2012-01 ,pp. : 63-80

Adis International

Access to resources Recommend Favorite

WHO has released a report calling on governments to commit more funds to fight multidrug-resistant tuberculosis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 548, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Clinical Pharmacology and Lesion Penetrating Properties of Second- and Third-Line Antituberculous Agents Used in the Management of Multidrug-Resistant (MDR) and Extensively-Drug Resistant (XDR) Tuberculosis

By  

Current Clinical Pharmacology, Vol. 5, Iss. 2, 2010-05 ,pp. : 96-114

Bentham Science Publishers

Access to resources Recommend Favorite